![]() Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates. | Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | ||
Founding Date | Founding Date 2006 | Founding Date 1978 | Founding Date 2008 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Houston, US HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | |
Employees | Employees 176% decrease | Employees 16,5612% increase | Employees 5,669 |
Valuation ($) | Valuation ($) 7.5 m | Valuation ($) N/A | Valuation ($) 8.8 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) ¥496.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) | Cost of goods ¥114.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ₹115.8b (FY, 2026) | Gross profit ¥383.4b (FY, 2025) |
Net income | Net income ($33.6m) (FY, 2025) | Net income ₹3.7b (FY, 2026) | Net income ¥67b (FY, 2025) |

Biocon is a company that develops and manufactures biopharmaceutical products.
View companyKyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company